Dr Michael Robson
Private nephrologist
London
Dr Robson is a highly experienced nephrologist (kidney doctor) who sees patients privately at in central London. His NHS practice is at Guy's and St Thomas' NHS Trust. He began his medical studies at Oxford University, where he obtained a First Class undergraduate degree in 1989, and then went to London for clinical studies. He trained in nephrology at King’s College and Guy’s Hospitals. Following the award of an MRC clinical training fellowship and research into glomerulonephritis, he gained a PhD from Imperial College in 2000. He has been a consultant nephrologist and Guy's and St Thomas’ since 2002.
His clinical practice covers all aspects of renal medicine including nephrology, dialysis and transplantation. He has a particular expertise in lupus, vasculitis and glomerulonephritis but is able to see and treat patients with any form of kidney disease.
Dr Robson is the nephrology lead in the lupus nephritis and vasculitis clinic at Guy's and St Thomas'. This clinic has one of the largest groups of patients with lupus nephritis in Europe.
Dr Robson runs a laboratory based research programme in glomerulonephritis and seeks to understand mechanisms of disease in order to discover new treatments.
He is also the Chief investigator in the PAVE trial, a multi-centre clinical trial funded by the National Institute for Health Research, aimed at preserving vascular access for haemodialysis. This trial has now finished recruitment and results should be available in 2020.
Dr Robson's publications are available here : Publications
GMC number 3659012 Robsonrenal is a partnership: names of partners available on request.
His clinical practice covers all aspects of renal medicine including nephrology, dialysis and transplantation. He has a particular expertise in lupus, vasculitis and glomerulonephritis but is able to see and treat patients with any form of kidney disease.
Dr Robson is the nephrology lead in the lupus nephritis and vasculitis clinic at Guy's and St Thomas'. This clinic has one of the largest groups of patients with lupus nephritis in Europe.
Dr Robson runs a laboratory based research programme in glomerulonephritis and seeks to understand mechanisms of disease in order to discover new treatments.
He is also the Chief investigator in the PAVE trial, a multi-centre clinical trial funded by the National Institute for Health Research, aimed at preserving vascular access for haemodialysis. This trial has now finished recruitment and results should be available in 2020.
Dr Robson's publications are available here : Publications
GMC number 3659012 Robsonrenal is a partnership: names of partners available on request.
